Factors Influencing Nocturnal Symptoms After Refractive Surgery.

September 6, 2023 updated by: Yifeng Yu, Second Affiliated Hospital of Nanchang University

Effects of Different Pupil Size Under Light and Dark Conditions on Nighttime Symptoms After Refractive Surgery.

By comparing the parameters of the two groups of patients with glare at night after refractive surgery and those without glare at night, the influence of preoperative related parameters on postoperative glare was analyzed.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangxi
      • Nanchang, Jiangxi, China, 330000
        • The Second Affiliated Hospital of Nanchang University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 41 years (Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

People undergoing refractive surgery.

Description

Inclusion criteria:

  • Age ≥18 years old;
  • Stable diopter (diopter change less than 0.5D in the past 2 years);
  • Best corrected distance visual acuity (CDVA) of 1.0 or better;
  • Anterior chamber depth (ACD) ≥2.8 mm;
  • Corneal endothelial cell density (ECD) ≥ 2 000 cells/mm.

Exclusion criteria:

  • History of ocular trauma or surgery;
  • Suspected keratoconus;
  • Previous history of other ocular diseases such as corneal inflammation or edema, glaucoma, uveitis, retinal detachment, macular degeneration, cataract, amblyopia, etc.;
  • History of severe dry eye;
  • Patients with systemic diseases, such as hyperthyroidism or autoimmune diseases; or severe mental disorders, such as anxiety and depression.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
glare group.
Patients subjectively complained about glare and Binoptometer examination showed poor visual quality in dark environments, and they were classified as the glare group.
refractive surgery
non-glare group
The patients did not complain of glare and the Binoptometer examination showed good visual quality in a dark environment, and they were classified as the non-glare group.
refractive surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of diopter under bright and dark pupils.
Time Frame: Preoperative
Use OPDScan Ⅲ to measure the parameters of both eyes
Preoperative
Changes of diopter under bright and dark pupils.
Time Frame: Day 7
Use OPDScan Ⅲ to measure the parameters of both eyes.
Day 7
Changes of diopter under bright and dark pupils.
Time Frame: Month 1
Use OPDScan Ⅲ to measure the parameters of both eyes.
Month 1
Changes of diopter under bright and dark pupils.
Time Frame: Month 3
Use OPDScan Ⅲ to measure the parameters of both eyes.
Month 3
Changes of diopter under bright and dark pupils.
Time Frame: Month 6
Use OPDScan Ⅲ to measure the parameters of both eyes.
Month 6
objective visual quality.
Time Frame: Day 7
Measurement of objective visual quality using Binopotometer.
Day 7
objective visual quality.
Time Frame: Month 1
Measurement of objective visual quality using Binopotometer and NIDEK Automatic computerized optometry instrument(ARK-1s).
Month 1
objective visual quality.
Time Frame: Month 3
Measurement of objective visual quality using Binopotometer.
Month 3
objective visual quality.
Time Frame: Month 6
Measurement of objective visual quality using Binopotometer.
Month 6
subjective visual quality
Time Frame: Day 7
Using visual quality questionnaire to evaluate patients' subjective visual quality.
Day 7
subjective visual quality
Time Frame: Month 1
Using visual quality questionnaire to evaluate patients' subjective visual quality.
Month 1
subjective visual quality
Time Frame: Month 3
Using visual quality questionnaire to evaluate patients' subjective visual quality.
Month 3
subjective visual quality
Time Frame: Month 6
Using visual quality questionnaire to evaluate patients' subjective visual quality.
Month 6
ICL Vault
Time Frame: Day 7
Measuring ICL vault with Pentacam
Day 7
ICL Vault
Time Frame: Month 1
Measuring ICL vault with Pentacam
Month 1
ICL Vault
Time Frame: Month 3
Measuring ICL vault with Pentacam
Month 3
ICL Vault
Time Frame: Month 6
Measuring ICL vault with Pentacam
Month 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2021

Primary Completion (Estimated)

December 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

November 20, 2022

First Submitted That Met QC Criteria

December 13, 2022

First Posted (Actual)

December 21, 2022

Study Record Updates

Last Update Posted (Actual)

September 7, 2023

Last Update Submitted That Met QC Criteria

September 6, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • [2021] No. (113).

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Refractive Surgery

Clinical Trials on refractive surgery

Subscribe